Radiogenomic analysis of prediction HER2 status in breast cancer by linking ultrasound radiomic feature module with biological functions

Table 1 Significance of clinical characteristics in train & test cohort

Clinical characteristics	HER2-Positive breast cancer	HER2-Negative breast cancer	p
No. of patients	179	215
Age	51.8 ± 9.9	52.7 ± 10.7	0.258
Lymph nodes			0.200
Positive	90	122
Negative	89	92
T			0.598
T1	75	86
T2	103	125
T3	1	4
N			0.102
N0	108	99
N1	51	115
N2	14	1
N3	6	0
M			0.102
M0	177	207
M1	2	8
TNM stage			0.795
I	53	57
II	103	144
II	21	5
IV	2	9
Menopausal.status			0.112
Menopausal	83	117
Premenopausal	96	98

ISSN: 1479-5876